News & Publications

Dr. Paul Nghiem, professor and head of Dermatology at the University of Washington and expert in Merkel cell carcinoma (MCC), joins the Seattle Translational Tumor Research leadership team as the Deputy Director for Skin/Cutaneous Oncology. As a hub for collaboration and innovation, Seattle Trans...

Click below for a statement from the National Comprehensive Cancer Network regarding coordination of care during the COVID-19 pandemic.   Click below for a statement from the National Comprehensive Cancer Network regarding COVID-19 vaccination for cancer patients.  

Amidst delays to treatment plans brought about by COVID-19, the FDA has approved a new dosing regimen of 400 mg every six weeks for pembrolizumab. The approval was based on pharmacokinetic modeling and exposure-response analyses that compared the predicted exposure of pembrolizumab 400 mg every s...

Dear Colleagues, Following cancellation of the AAD meeting in Denver, we initially planned to proceed with a virtual (Zoom-based) meeting for our Merkel interest group. We had 5 very interesting talks lined up & all speakers were available. Given the urgency of COVID-19-associated event...

For more information, click here.

Dear friends of Merkel cell carcinoma research, During this time of giving and celebrations, I want to let you know how appreciative our Merkel Team is of your support.  This year was one of many exciting milestones that I am thrilled to share with you.   We have written an annual update lette...

A study with the longest follow-up of immunotherapy as the first line treatment for patients with advanced MCC has showed improved overall survival and response rate compared to controls. The study included 50 treatment naïve adults with advanced MCC who received a median of 10.5 doses of pembroliz...

3 generations of mentor-mentees gathered in Aomori Japan at the Japanese Society for Investigative Dermatology. DOM members Drs Masaoki Kawasumi, Tomoko Akaike, and Paul Nghiem, all gave plenary session talks. Left to right: Tomoko Akaike is a Japanese dermatologist doing a clinical research ...

PLEASE NOTE: this site is in its early stages of development and the underlying predictive model has not yet been finalized or undergone peer review. If you have questions or feedback, please email aard@uw.edu Disclaimer: No Medical Advice. ALTHOUGH SOME CONTENT MAY BE PROVIDED BY INDIVIDU...

In October 2017, a multidisciplinary symposium on new developments in the comprehensive management of Merkel cell carcinoma was held at the University of Rochester Medical Center. The event included specialists across many disciplines such as dermatology, surgical oncology, otolaryngology, radiation...